Cervical Cancer Trial, Recruiting (NCT06850974)

Cervical Cancer Trial, Recruiting NCT06850974 Sponsor: Stony Brook University Condition: Cervical Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06850974 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cervical Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women aged 18 or older who are attending Hospital Central de Maputo and need to end a pregnancy for a legally accepted reason, at 16 to 21 weeks of pregnancy
People who speak Portuguese

Who may not be able to join:

People under the age of 18
People who are currently in prison or detained
People who have an infection of the membranes surrounding the baby (confirm with trial site)
People who are currently experiencing heavy bleeding
People who have a known condition that affects their blood's ability to clot
People whose blood pressure or circulation is dangerously unstable
People whose cervix is already open more than 2 centimetres
People who have previously had a procedure to stitch the cervix closed (cervical cerclage)
People who are allergic to any of the medications used in the study
People who have a serious pregnancy-related condition involving high blood pressure and seizures (eclampsia)
People who are not fully alert or aware, as measured by a standard medical awareness test (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +258 84 147 7208

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06850974

Sponsor: Stony Brook University

Phase: Not Applicable

Status: Recruiting

Condition: Cervical Cancer

Trial contact: +258 84 147 7208

More information: https://clinicaltrials.gov/study/NCT06850974

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women aged 18 or older who are attending Hospital Central de Maputo and need to end a pregnancy for a legally accepted reason, at 16 to 21 weeks of pregnancy
People who speak Portuguese

Who may not be able to join:

People under the age of 18
People who are currently in prison or detained
People who have an infection of the membranes surrounding the baby (confirm with trial site)
People who are currently experiencing heavy bleeding
People who have a known condition that affects their blood's ability to clot
People whose blood pressure or circulation is dangerously unstable
People whose cervix is already open more than 2 centimetres
People who have previously had a procedure to stitch the cervix closed (cervical cerclage)
People who are allergic to any of the medications used in the study
People who have a serious pregnancy-related condition involving high blood pressure and seizures (eclampsia)
People who are not fully alert or aware, as measured by a standard medical awareness test (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Stony Brook University

Registry

ClinicalTrials.gov

Start date

10 February 2025

Est. completion

1 March 2027

Where this trial is recruiting

Mozambique

Primary endpoints

Total Procedure Time (TPT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov